The Gross Law Firm Announces Class Actions on Behalf of Shareholders of TCMD, RTX and YY

The MarketWatch News Department was not involved in the creation of this content.

November 30, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 30, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Tactile Systems Technology, Inc. (NASDAQ:TCMD)

Investors Affected : May 7, 2018 – June 8, 2020

A class action has commenced on behalf of certain shareholders in Tactile Systems Technology, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) while Tactile publicly touted a $4 plus billion or $5 plus billion market

Read More

Top consulting firm McKinsey suggested Purdue Pharma give pharmacies rebates for OxyContin overdoses

One of the most prestigious consulting firms in the world, McKinsey & Company, advised Purdue Pharma to give pharmacy companies rebates for OxyContin overdoses in 2017, according to records released last week in a federal bankruptcy court in New York.



a sign on the side of a building: Top consulting firm McKinsey suggested Purdue Pharma give pharmacies rebates for OxyContin overdoses


© Getty
Top consulting firm McKinsey suggested Purdue Pharma give pharmacies rebates for OxyContin overdoses

Documents submitted to the court last week revealed that McKinsey had allegedly given advice to the Sackler family on ways to boost sales of Oxycontin in the middle of the opioid epidemic, according to a report from The New York Times.

Loading...

Load Error

The documents, filed on behalf of several states’ attorneys general, reportedly revealed that during a 2017 meeting, Mckinsey allegedly suggested that Purdue give a rebate for every OxyContin overdose linked to the pills that pharmacy companies such as CVS sold, according to the Times.

The 2017 presentation allegedly estimated the number of

Read More

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BTU, RTX and ICPT

The MarketWatch News Department was not involved in the creation of this content.

November 25, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 25, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Peabody Energy Corporation (NYSE:BTU)Class Period: April 3, 2017 – October 28, 2019Lead Plaintiff Deadline: November 27, 2020

The BTU lawsuit alleges Peabody Energy Corporation made materially false and/or misleading statements and/or failed to disclose during the class period that: (a) the Company had failed to implement adequate safety controls at the North Goonyella mine to prevent the risk of a spontaneous combustion event; (b) the Company failed to follow

Read More

Northern VA Sales Consulting Firm Discusses Sales Negotiation Consulting

RCG Workgroup | Northern VA Sales Consulting Firm

RCG Workgroup, a Northern Virginia Sales consulting firm, recently released a blog educating readers on sales negotiation consulting. The article goes over the details of sales negotiation consulting and why the art of negotiation is so important.

Fairfax, Virginia – November 27, 2020 – RCG Workgroup, a Northern Virginia sales consulting firm, has recently released a new educational resource that explains the importance of sales negotiation consulting. The information in the article is guided by the sales consulting experts at RCG who understand the power of proper training. They go over how these techniques can teach sales professionals to have better interactions with prospective customers while building relationships of trust that can be converted into mutually beneficial opportunities.

RCG Workgroup offers readers some valuable information that can help explain why sales negotiation consulting services can be so transformative for businesses. In the

Read More

Northern VA Sales Consulting Firm Discusses Sales Negotiation Consulting – Press Release

RCG Workgroup | Northern VA Sales Consulting Firm

RCG Workgroup, a Northern Virginia Sales consulting firm, recently released a blog educating readers on sales negotiation consulting. The article goes over the details of sales negotiation consulting and why the art of negotiation is so important.

Fairfax, Virginia – November 27, 2020 – RCG Workgroup, a Northern Virginia sales consulting firm, has recently released a new educational resource that explains the importance of sales negotiation consulting. The information in the article is guided by the sales consulting experts at RCG who understand the power of proper training. They go over how these techniques can teach sales professionals to have better interactions with prospective customers while building relationships of trust that can be converted into mutually beneficial opportunities.

RCG Workgroup offers readers some valuable information that can help explain why sales negotiation consulting services can be so transformative for businesses. In the

Read More

Bronstein, Gewirtz & Grossman, LLC Reminds Biogen Inc. Investors of Class Action and Encourages Investors to Contact the Firm

Press release content from Business Wire. The AP news staff was not involved in its creation.

NEW YORK–(BUSINESS WIRE)–Nov 23, 2020–

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Biogen securities pursuant between October 22, 2019 and November 6, 2020, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/biib.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness;

Read More

Pomerantz Law Firm Announces the Filing of a Class Action against Fortress Biotech, Inc. Certain Officers – FBIO

NEW YORK, Nov. 27, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc.  (“Fortress” or the “Company”) (NASDAQ: FBIO) and certain of its officers.  The class action, filed in United States District Court for the Eastern District of New York, and docketed under 20-cv-05767, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fortress securities between December 11, 2019 and October 9, 2020, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Fortress securities during the

Read More

Pomerantz Law Firm Announces the Filing of a Class Action against Neovasc Inc. and Certain Officers – NVCN

NEW YORK, Nov. 25, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) and certain of its officers.  The class action, filed in United States District Court for the Southern District of New York, and docketed under 20-cv-09948, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Neovasc securities between October 10, 2018 and October 27, 2020, inclusive (the “Class Period”).  Plaintiff pursues claims against the Defendants under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Neovasc securities during the Class Period, you have until January 5, 2021, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action,

Read More

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BMRN, CACC and TRQ

The MarketWatch News Department was not involved in the creation of this content.

November 24, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 24, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Investors Affected : February 28, 2020 – August 18, 2020

A class action has commenced on behalf of certain shareholders in BioMarin Pharmaceutical Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) differences between the Phase 1/2 and Phase 3 study of valoctocogene roxaparvovec, an investigational adenoassociated

Read More

Pomerantz Law Firm Announces the Filing of a Class Action against Neovasc Inc. and Certain Officers

NEW YORK, Nov. 25, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN) and certain of its officers.  The class action, filed in United States District Court for the Southern District of New York, and docketed under 20-cv-09948, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Neovasc securities between October 10, 2018 and October 27, 2020, inclusive (the “Class Period”).  Plaintiff pursues claims against the Defendants under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Neovasc securities during the Class Period, you have until January 5, 2021, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com.   To discuss this action,

Read More